ACHIEVEMENT OF LONG-TERM TREATMENT GOALS WITH UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF INDUCTION AND MAINTENANCE PHASE 3 TRIALS

Julian Panés  ¹     Remo Panaccione  ²     Marla C. Dubinsky  ³     Yoh Ishiguro  ⁴     Jacinda Tran  ^{5, 6}     Dapo Ilo  ⁶     Jason Eccleston  ⁶     Yuri Sanchez Gonzalez  ⁶     Brian G. Feagan  ^7    
1 Hospital Clinic Barcelona, Barcelona, Spain
² University of Calgary, Calgary, Canada
³ Icahn School of Medicine, Mount Sinai, New York City, United States
⁴ National Hirosaki Hospital, Hirosaki, Japan
⁵ University of Washington, Seattle, United States
⁶ AbbVie, Inc, North Chicago, United States
⁷ The University of Western Ontario, London, Canada

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)